One Spitalfields: what a £1.016bn loan signals for development finance

A £1.016bn facility for One Spitalfields shows that substantial bank capital remains available for selected office redevelopments. The more important signal is why this scheme differs from projects facing weaker demand and greater delivery pressure.

Read Article

Oct 1, 2026

Button

Finance

Button

A major facility, but not a market-wide verdict

Bridging Loan Directory reports that DBS and ING have provided a £1.016bn development loan for the refurbishment of One Spitalfields, underwriting equal shares of the facility. DBS is global coordinator, while both banks are mandated lead arrangers, bookrunners and green-loan coordinators. The scale is notable, but the transaction should not be interpreted as evidence that development finance conditions have eased uniformly. It instead illustrates the characteristics capable of attracting substantial bank commitments in a selective market.

The pre-let changes the financing context

Jane Street has agreed terms to pre-let 465,000 sq ft for its London expansion. The refurbished 11-storey building is expected to provide more than 700,000 sq ft, meaning a substantial amount of its planned accommodation is associated with an occupier before redevelopment begins. This does not remove construction, programme or letting risk, but it gives lenders greater visibility over the scheme’s future occupational profile and reduces its reliance on fully speculative demand.

Michael Ramm, head of J.P. Morgan Asset Management European Real Estate, attributed lender appetite to the team’s development record and demand for prime locations with institutional tenants. That combination is central to the financing analysis. In the current environment described by Bridging Loan Directory, capital appears available where sponsor capability, location and occupier commitment form a coherent credit case. Projects lacking one or more of these features may face a materially different lender response.

Sequencing will remain critical

CBRE said the existing tenant plans to leave in May 2027, after which J.P. Morgan Asset Management will undertake the redevelopment. Completion is expected in 2029. This timetable highlights the importance of aligning the facility with possession, construction and delivery milestones. For developers, an early financing commitment can provide strategic certainty, but lender diligence will still need to address the period between the existing tenant’s departure and completion of the refurbished building.

Environmental targets are part of the funding proposition

One Spitalfields is targeting an EPC A rating and BREEAM Outstanding certification. The proposals retain the building’s structural frame, with consultation materials stating that most of the existing structure would be preserved to reduce environmental impact and disruption. The appointment of both lenders as green-loan coordinators indicates that the environmental programme is integrated into the financing structure rather than treated solely as a design consideration.

For sponsors pursuing refurbishment strategies, this transaction demonstrates how retained structure, certification targets and occupier requirements can be presented as connected elements of the business plan. However, ambitious environmental objectives also need to be supported by a credible scope, delivery programme and reporting framework. The labels attached to a facility do not substitute for execution.

A bifurcated development market

The contrast with residential development finance is important. Bridging Loan Directory also cites Close Brothers’ annual results, which identified planning complexity, elevated construction costs and lower purchaser demand as pressures on its core build-to-sell market. The lender’s Property division reported a 27% decline in adjusted operating profit to £49m, reflecting softer demand, lower loan balances and increased impairment charges on a small number of facilities. Close Brothers is also expanding its focus on larger corporate borrowers, structured finance and Build-to-Rent.

These two developments point to a financing market divided by asset strategy, demand visibility and sponsor profile. One Spitalfields benefits from an institutional ownership context and a large pre-let, while build-to-sell schemes depend on future individual purchaser demand. The appropriate capital structure, lender universe and evidence required to support underwriting will therefore vary considerably between projects.

Implications for borrowers and investors

  • Early occupier engagement can strengthen the commercial narrative and reduce dependence on speculative letting.

  • A sponsor’s delivery record may carry significant weight where the proposed facility and construction programme are substantial.

  • Environmental targets should be embedded in design, monitoring and finance documentation from the outset.

  • Borrowers should distinguish between headline liquidity and the availability of funding for their specific asset, strategy and risk profile.

The central message is not that large development loans have become straightforward. It is that lenders can still commit significant capital when the scheme offers strong sponsorship, visible occupational demand and a clearly defined redevelopment plan. For other developers and investors, the priority is to identify which risks can be reduced before approaching the market and which must be addressed through the proposed financing structure.

*Risk Warning: Don't invest unless you're prepared to lose money. Property investment is high-risk and you may not be able to access your money easily. Past performance is not a reliable indicator of future results. The information provided does not constitute investment advice. If you are unsure about property investment, please seek independent financial advice.

Palladium Capital acts as an intermediary and does not provide legal, tax, or investment advice. All investors should conduct their own due diligence.

Palladium Capital Ltd is a company registered in England and Wales. Registered office: 3rd floor, 45 albermarle street, Mayfair, London W1S 4JL.

*Risk Warning: Don't invest unless you're prepared to lose money. Property investment is high-risk and you may not be able to access your money easily. Past performance is not a reliable indicator of future results. The information provided does not constitute investment advice. If you are unsure about property investment, please seek independent financial advice.

Palladium Capital acts as an intermediary and does not provide legal, tax, or investment advice. All investors should conduct their own due diligence.

Palladium Capital Ltd is a company registered in England and Wales. Registered office: 3rd floor, 45 albermarle street, Mayfair, London W1S 4JL.

*Risk Warning: Don't invest unless you're prepared to lose money. Property investment is high-risk and you may not be able to access your money easily. Past performance is not a reliable indicator of future results. The information provided does not constitute investment advice. If you are unsure about property investment, please seek independent financial advice.

Palladium Capital acts as an intermediary and does not provide legal, tax, or investment advice. All investors should conduct their own due diligence.

Palladium Capital Ltd is a company registered in England and Wales. Registered office: 3rd floor, 45 albermarle street, Mayfair, London W1S 4JL.